Mucocutaneous complications of smoking cessation therapies.
Despite widespread knowledge of the morbidity and mortality associated with smoking, this addictive practice continues to be quite prevalent throughout the United States, as about one-fifth of the population smokes cigarettes. Because of the financial burden, and the significant psychosocial and health implications of smoking, many individuals are now attempting to quit, and often using some type of pharmacotherapy for assistance. Given that dermatologists will likely encounter patients using smoking cessation aids, it is important to be aware of their potential mucocutaneous adverse effects. We present a brief review of the dermatologic complications associated with smoking cessation therapies. Hopefully, this article will also remind dermatologists to encourage smoking cessation at every visit.
Department of Dermatology, Duke University Medical Center, Durham, North Carolina 27710, USA. barryladizinski@gmail.com
Barry
B
Ladizinski
Kachiu Cecilia
KC
Lee
D006801:Humans; D009061:Mouth Mucosa / Q000187:drug effects*; D020545:Respiratory Mucosa / Q000187:drug effects*; D012871:Skin Diseases / Q000139:chemically induced*; D061485:Tobacco Use Cessation Devices / Q000009:adverse effects*